Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebre

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Acta Reumatologica Portuguesa|March 18, 2008
Dendritic cell subsets: their roles in rheumatoid arthritisMaria C Lebre, Paul P Tak
Autoimmunity Reviews|October 12, 2013
Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammationM I Ramos, P P Tak, M C Lebre
Archives of Dermatological Research|September 11, 1999
Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitorsM C Lebre, P Kalinski, P K Das, et al.
Acta Pharmaceutica Sinica. B|September 2, 2025
Resistance mutations and the blood-brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancerJamie Rijmers, Maria C Lebre, Jos H Beijnen, et al.
Toxicology and Applied Pharmacology|May 30, 2020
Human organic anion transporting polypeptide (OATP) 1B3 and mouse OATP1A/1B affect liver accumulation of Ochratoxin A in miceJing Wang, Changpei Gan, Xiaozhe Qi, et al.
Pharmaceutics|November 27, 2021
ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral AvailabilityWenlong Li, Rolf W Sparidans, Maria C Lebre, et al.
Scandinavian Journal of Rheumatology|January 6, 2006
The role of chemokines in rheumatoid arthritis and osteoarthritisC E Vergunst, M G H van de Sande, M C Lebre, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2019
Oral coadministration of elacridar and ritonavir enhances brain accumulation and oral availability of the novel ALK/ROS1 inhibitor lorlatinibWenlong Li, Rolf W Sparidans, Yaogeng Wang, et al.
Pharmacological Research|September 26, 2018
P-glycoprotein and breast cancer resistance protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availabilityWenlong Li, Rolf W Sparidans, Yaogeng Wang, et al.
International Journal of Cancer|July 16, 2019
P-glycoprotein (MDR1/ABCB1) controls brain accumulation and intestinal disposition of the novel TGF-β signaling pathway inhibitor galunisertibWenlong Li, Matthijs Tibben, Yaogeng Wang, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Acta Reumatologica Portuguesa|March 18, 2008
Dendritic cell subsets: their roles in rheumatoid arthritisMaria C Lebre, Paul P Tak
Autoimmunity Reviews|October 12, 2013
Fms-like tyrosine kinase 3 ligand-dependent dendritic cells in autoimmune inflammationM I Ramos, P P Tak, M C Lebre
Archives of Dermatological Research|September 11, 1999
Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitorsM C Lebre, P Kalinski, P K Das, et al.
Acta Pharmaceutica Sinica. B|September 2, 2025
Resistance mutations and the blood-brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancerJamie Rijmers, Maria C Lebre, Jos H Beijnen, et al.
Toxicology and Applied Pharmacology|May 30, 2020
Human organic anion transporting polypeptide (OATP) 1B3 and mouse OATP1A/1B affect liver accumulation of Ochratoxin A in miceJing Wang, Changpei Gan, Xiaozhe Qi, et al.
Pharmaceutics|November 27, 2021
ABCB1 and ABCG2 Control Brain Accumulation and Intestinal Disposition of the Novel ROS1/TRK/ALK Inhibitor Repotrectinib, While OATP1A/1B, ABCG2, and CYP3A Limit Its Oral AvailabilityWenlong Li, Rolf W Sparidans, Maria C Lebre, et al.
Scandinavian Journal of Rheumatology|January 6, 2006
The role of chemokines in rheumatoid arthritis and osteoarthritisC E Vergunst, M G H van de Sande, M C Lebre, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 21, 2019
Oral coadministration of elacridar and ritonavir enhances brain accumulation and oral availability of the novel ALK/ROS1 inhibitor lorlatinibWenlong Li, Rolf W Sparidans, Yaogeng Wang, et al.
Pharmacological Research|September 26, 2018
P-glycoprotein and breast cancer resistance protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availabilityWenlong Li, Rolf W Sparidans, Yaogeng Wang, et al.
International Journal of Cancer|July 16, 2019
P-glycoprotein (MDR1/ABCB1) controls brain accumulation and intestinal disposition of the novel TGF-β signaling pathway inhibitor galunisertibWenlong Li, Matthijs Tibben, Yaogeng Wang, et al.
Pageof 6